Free-Webinar: CMC Quality Challenges for Cell Therapy Products

Online
15:00
-
16:00
Salud
Acceso a la innovación
webinar-revio-biotech

Discussing the most common quality challenges faced in the development of ATMPs: Starting Materials, Characterisation, Comparability, Potency or Viral Safety, among others.

Held by Maria Reviriego, Executive Regulatory Consultant and Founder of Revio, ex-regulator at MHRA and former Regulatory Affairs Head in the development of Alofisel, the first allogeneic cell therapy approved in Europe.

Contact: